Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells

Surgery

Volumn 141, Issue 6, 2007, Pages 804-814

  Grzesiak, John J ^a   Smith, Kathy C ^b   Burton, Douglas W ^b   Deftos, Leonard J ^b   Bouvet, Michael ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; INTEGRIN; INTERLEUKIN 8; LAMININ 1; SCLEROPROTEIN; STROMAL CELL DERIVED FACTOR 1; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 6; VITRONECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL LYSATE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOBLOTTING; METASTASIS; MIGRATION INHIBITION; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINES, CXC; CHEMOTAXIS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INTEGRIN ALPHA3BETA1; INTEGRIN ALPHA6BETA1; INTEGRINS; INTERLEUKIN-8; LAMININ; PANCREATIC NEOPLASMS; RECEPTORS, CXCR4; UP-REGULATION;

EID: 34249779852     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.12.016     Document Type: Article

References (55)

1. Bardeesy N., and DePinho R.A. Pancreatic cancer biology and genetics. Nat Rev Cancer 2 (2002) 897-909
2. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12 (1996) 697-715
3. Weinel R.J., Rosendahl A., Neumann K., Chaloupka B., Erb D., Rothmund M., et al. Expression and function of VLA-alpha 2, -alpha 3, -alpha 5 and -alpha 6-integrin receptors in pancreatic carcinoma. Int J Cancer 52 (1992) 827-833
4. Rosendahl A., Neumann K., Chaloupka B., Rothmund M., and Weinel R.J. Expression and distribution of VLA receptors in the pancreas: an immunohistochemical study. Pancreas 8 (1993) 711-718
5. Shimoyama S., Gansauge F., Gansauge S., Oohara T., and Beger H.G. Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas. Int J Pancreatol 18 (1995) 227-234
6. Linder S., Castanos-Velez E., von Rosen A., and Biberfeld P. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology 48 (2001) 1321-1327
7. Iacobuzio-Donahue C.A., Ashfaq R., Maitra A., Adsay N.V., Shen-Ong G.L., Berg K., et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63 (2003) 8614-8622
8. Binkley C.E., Zhang L., Greenson J.K., Giordano T.J., Kuick R., Misek D., et al. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas 29 (2004) 254-263
9. Stein W.D., Litman T., Fojo T., and Bates S.E. A serial analysis of gene expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins. Cancer Res 64 (2004) 2805-2816
10. Mollenhauer J., Roether I., and Kern H.F. Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas 2 (1987) 14-24
11. Grzesiak J.J., and Bouvet M. The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer 94 (2006) 1311-1319
12. Grzesiak J.J., Smith K.C., Chalberg C., Burton D.W., Deftos L.J., and Bouvet M. Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells. Int J Gastrointest Cancer 36 (2005) 131-146
13. Grzesiak J.J., Clopton P., Chalberg C., Smith K., Burton D.W., Silletti S., et al. The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells. Pancreas 29 (2004) 85-92
14. Grzesiak J.J., Smith K.C., Burton D.W., Deftos L.J., and Bouvet M. GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells. Int J Cancer 114 (2005) 522-530
15. 1 integrins in a novel three-dimensional in vitro model of pancreatic cancer. Pancreas 34 (2007) 220-228
16. Bachem M.G., Schunemann M., Ramadani M., Siech M., Beger H., Buck A., et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128 (2005) 907-921
17. Armstrong T., Packham G., Murphy L.B., Bateman A.C., Conti J.A., Fine D.R., et al. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 10 (2004) 7427-7437
18. Vogelmann R., Kreuser E.D., Adler G., and Lutz M.P. Integrin alpha6beta1 role in metastatic behavior of human pancreatic carcinoma cells. Int J Cancer 80 (1999) 791-795
19. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
20. Uchida D., Begum N.M., Tomizuka Y., Bando T., Almofti A., Yoshida H., et al. Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Lab Invest 84 (2004) 1538-1546
21. Koshiba T., Hosotani R., Miyamoto Y., Ida J., Tsuji S., Nakajima S., et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6 (2000) 3530-3535
22. Marchesi F., Monti P., Leone B.E., Zerbi A., Vecchi A., Piemonti L., et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64 (2004) 8420-8427
23. Mori T., Doi R., Koizumi M., Toyoda E., Ito D., Kami K., et al. CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 3 (2004) 29-37
24. Shi Q., Abbruzzese J.L., Huang S., Fidler I.J., Xiong Q., and Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 5 (1999) 3711-3721
25. Becker C., Fantini M.C., Schramm C., Lehr H.A., Wirtz S., Nikolaev A., et al. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21 (2004) 491-501
26. Wigmore S.J., Fearon K.C., Sangster K., Maingay J.P., Garden O.J., and Ross J.A. Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol 21 (2002) 881-886
27. Sonnenberg A., Modderman P.W., and Hogervorst F. Laminin receptor on platelets is the integrin VLA-6. Nature 336 (1988) 487-489
28. Wayner E.A., and Carter W.G. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol 105 (1987) 1873-1884
29. Wayner E.A., Carter W.G., Piotrowicz R.S., and Kunicki T.J. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 107 (1988) 1881-1891
30. Wayner E.A., Gil S.G., Murphy G.F., Wilke M.S., and Carter W.G. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol 121 (1993) 1141-1152
31. Pattaramalai S., Skubitz K.M., and Skubitz A.P. A novel recognition site on laminin for the alpha 3 beta 1 integrin. Exp Cell Res 222 (1996) 281-290
32. Cheresh D.A., and Spiro R.C. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem 262 (1987) 17703-17711
33. Hoffstrom B.G., and Wayner E.A. Immunohistochemical techniques to study the extracellular matrix and its receptors. Methods Enzymol 245 (1994) 316-346
34. Grzesiak J.J., Davis G.E., Kirchhofer D., and Pierschbacher M.D. Regulation of alpha 2 beta 1-mediated fibroblast migration on type I collagen by shifts in the concentrations of extracellular Mg2+ and Ca2+. J Cell Biol 117 (1992) 1109-1117
35. Li X., Ma Z., Zhu J., Li K., Wang S., Bie P., and Dong J. Laminin-5 promotes cell motility by regulating the function of the integrin alpha6beta1 in pancreatic cancer. Carcinogenesis 25 (2004) 2283
36. Sawai H., Yamamoto M., Okada Y., Sato M., Akamo Y., Takeyama H., et al. Alteration of integrins by interleukin-1alpha in human pancreatic cancer cells. Pancreas 23 (2001) 399-405
37. Miura K., Uniyal S., Leabu M., Oravecz T., Chakrabarti S., Morris V.L., et al. Chemokine receptor CXCR4-beta1 integrin axis mediates tumorigenesis of osteosarcoma HOS cells. Biochem Cell Biol 83 (2005) 36-48
38. Hartmann T.N., Burger J.A., Glodek A., Fujii N., and Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 24 (2005) 4462-4471
39. Attur M.G., Dave M.N., Clancy R.M., Patel I.R., Abramson S.B., and Amin A.R. Functional genomic analysis in arthritis-affected cartilage: yin-yang regulation of inflammatory mediators by alpha 5 beta 1 and alpha V beta 3 integrins. J Immunol 164 (2000) 2684-2691
40. Dogic D., Rousselle P., and Aumailley M. Cell adhesion to laminin 1 or 5 induces isoform-specific clustering of integrins and other focal adhesion components. J Cell Sci 111 (1998) 793-802
41. Lauer J.L., Gendron C.M., and Fields G.B. Effect of ligand conformation on melanoma cell alpha3beta1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion. Biochemistry 37 (1998) 5279-5287
42. Friedl P., Noble P.B., and Zanker K.S. T lymphocyte locomotion in a three-dimensional collagen matrix. Expression and function of cell adhesion molecules. J Immunol 154 (1995) 4973-4985
43. Garcia-Velasco J.A., and Arici A. Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion. Mol Hum Reprod 5 (1999) 1135-1140
44. Rezzonico R., Imbert V., Chicheportiche R., and Dayer J.M. Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB. Blood 97 (2001) 2932-2940
45. Lowrie A.G., Salter D.M., and Ross J.A. Latent effects of fibronectin, alpha5beta1 integrin, alphaVbeta5 integrin and the cytoskeleton regulate pancreatic carcinoma cell IL-8 secretion. Br J Cancer 91 (2004) 1327-1334
46. Miyamoto H., Murakami T., Tsuchida K., Sugino H., Miyake H., and Tashiro S. Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 28 (2004) 38-44
47. Vaquero E.C., Edderkaoui M., Nam K.J., Gukovsky I., Pandol S.J., and Gukovskaya A.S. Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways. Gastroenterology 125 (2003) 1188-1202
48. Toyoda E., Doi R., Koizumi M., Kami K., Ito D., Mori T., et al. Analysis of E-, N-cadherin, alpha-, beta-, and gamma-catenin expression in human pancreatic carcinoma cell lines. Pancreas 30 (2005) 168-173
49. Weinel R.J., Neumann K., Kisker O., and Rosendahl A. Expression and potential role of E-cadherin in pancreatic carcinoma. Int J Pancreatol 19 (1996) 25-30
50. Katz M.H., Takimoto S., Spivack D., Moossa A.R., Hoffman R.M., and Bouvet M. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Clin Exp Metastasis 21 (2004) 7-12
51. Katz M.H., Bouvet M., Takimoto S., Spivack D., Moossa A.R., and Hoffman R.M. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Cancer Res 64 (2004) 1828-1833
52. Katz M.H., Bouvet M., Takimoto S., Spivack D., Moossa A.R., and Hoffman R.M. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer. Cancer Res 63 (2003) 5521-5525
53. Katz M.H., Takimoto S., Spivack D., Moossa A.R., Hoffman R.M., and Bouvet M. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113 (2003) 151-160
54. Katz M.H., Spivack D.E., Takimoto S., Fang B., Burton D.W., Moossa A.R., et al. Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter. Ann Surg Oncol 10 (2003) 762-772
55. Anaya-Prado R., Toledo-Pereyra L.H., Collins J.T., Smejkal R., McClaren J., Crouch L.D., et al. Dual blockade of P-selectin and beta2-integrin in the liver inflammatory response after uncontrolled hemorrhagic shock. J Am Coll Surg 187 (1998) 22-31